These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 18472208

  • 1. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection.
    Liu HT, Chancellor MB, Kuo HC.
    Eur Urol; 2009 Oct; 56(4):700-6. PubMed ID: 18472208
    [Abstract] [Full Text] [Related]

  • 2. Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment.
    Roosen A, Datta SN, Chowdhury RA, Patel PM, Kalsi V, Elneil S, Dasgupta P, Kessler TM, Khan S, Panicker J, Fry CH, Brandner S, Fowler CJ, Apostolidis A.
    Eur Urol; 2009 Jun; 55(6):1440-8. PubMed ID: 19054608
    [Abstract] [Full Text] [Related]

  • 3. Editorial comment on: Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection.
    Novara G.
    Eur Urol; 2009 Oct; 56(4):706-7. PubMed ID: 18472211
    [No Abstract] [Full Text] [Related]

  • 4. Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder.
    Liu HT, Chancellor MB, Kuo HC.
    BJU Int; 2009 Jun; 103(12):1668-72. PubMed ID: 19220267
    [Abstract] [Full Text] [Related]

  • 5. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.
    Liu HT, Kuo HC.
    Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272
    [Abstract] [Full Text] [Related]

  • 6. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
    Liu HT, Tyagi P, Chancellor MB, Kuo HC.
    BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
    [Abstract] [Full Text] [Related]

  • 7. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention.
    Liu HT, Kuo HC.
    Neurourol Urodyn; 2009 Nov; 28(1):78-81. PubMed ID: 19089891
    [Abstract] [Full Text] [Related]

  • 8. Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.
    Apostolidis A, Jacques TS, Freeman A, Kalsi V, Popat R, Gonzales G, Datta SN, Ghazi-Noori S, Elneil S, Dasgupta P, Fowler CJ.
    Eur Urol; 2008 Jun; 53(6):1245-53. PubMed ID: 18343564
    [Abstract] [Full Text] [Related]

  • 9. Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity.
    Kalsi V, Apostolidis A, Gonzales G, Elneil S, Dasgupta P, Fowler CJ.
    Eur Urol; 2008 Jul; 54(1):181-7. PubMed ID: 18191323
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection.
    Kuo HC.
    Urology; 2008 Nov; 72(5):1056-60. PubMed ID: 18533231
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence.
    Kuo HC, Liu HT, Chancellor MB.
    Neurourol Urodyn; 2010 Mar; 29(3):482-7. PubMed ID: 19367641
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity.
    Gamé X, Khan S, Panicker JN, Kalsi V, Dalton C, Elneil S, Hamid R, Dasgupta P, Fowler CJ.
    BJU Int; 2011 Jun; 107(11):1786-92. PubMed ID: 21040367
    [Abstract] [Full Text] [Related]

  • 17. Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics.
    Kuo HC.
    Urology; 2005 Jul; 66(1):94-8. PubMed ID: 15992869
    [Abstract] [Full Text] [Related]

  • 18. Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy.
    Liu HT, Lin H, Kuo HC.
    Neurourol Urodyn; 2011 Nov; 30(8):1525-9. PubMed ID: 21826717
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.